T-CELL RICH B-CELL LYMPHOMA
Clinical trials for T-CELL RICH B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL RICH B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL RICH B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy hopes to tackle tough lymphoma
Disease control OngoingThis early-phase trial is testing a new drug called venetoclax combined with standard chemotherapy drugs for people with aggressive B-cell lymphoma that has come back or stopped responding to treatment. The main goal is to find the highest safe dose of the new combination. About …
Matched conditions: T-CELL RICH B-CELL LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New cocktail of drugs tested for Tough-to-Treat lymphoma
Disease control OngoingThis phase 2 trial is testing several new drug combinations for people with aggressive B-cell lymphoma that has come back or not responded to standard therapy. About 129 participants will receive one of several experimental combinations, including drugs like ibrutinib and selinex…
Matched conditions: T-CELL RICH B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Blood test may replace CT scans for lymphoma patients
Knowledge-focused OngoingThis study looks at whether a blood test can spot signs of lymphoma coming back after chemotherapy, possibly earlier than regular CT scans. About 500 adults with aggressive B-cell Non-Hodgkin lymphoma will give blood samples after treatment. The goal is to see if this test could …
Matched conditions: T-CELL RICH B-CELL LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC